Glassy Mountain Advisors Inc. Buys 889 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Glassy Mountain Advisors Inc. grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 10.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,196 shares of the healthcare conglomerate’s stock after buying an additional 889 shares during the period. UnitedHealth Group accounts for about 1.7% of Glassy Mountain Advisors Inc.’s holdings, making the stock its 25th biggest holding. Glassy Mountain Advisors Inc.’s holdings in UnitedHealth Group were worth $4,816,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group in the fourth quarter valued at $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth $32,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

UNH opened at $307.69 on Thursday. The stock has a market capitalization of $279.12 billion, a P/E ratio of 12.88, a PEG ratio of 1.55 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The stock has a 50-day moving average price of $329.50 and a 200-day moving average price of $450.21.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter in the previous year, the firm posted $6.91 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.87%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,533 shares of the company’s stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director owned 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer directly owned 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on UNH shares. Wolfe Research cut their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research report on Tuesday, May 20th. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Raymond James Financial lowered UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. TD Securities reissued a “hold” rating and set a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Finally, Hsbc Global Res cut UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, May 21st. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $415.57.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.